Loading, please wait ...


News Analytics

press release cancer killing virus therapy shows promise.
Funding support for the study, known as CAPRA, was provided by Viralytics, the manufacturer of the V937 drug used in the experiments, and by Merck of Kenilworth, New Jersey, which owns Viralytics and produces pembrolizumab, the other drug involved in the research.
Google

Subject Matter

  • Healthcare 59.74%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 40.26%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions